Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP306 versus DT booster vaccination in Japanese adolescents
2015-003950-41Phase 3
- Sponsor
- Sanofi
- Start
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of acellular pertussis vaccine and diphtheria toxoid adsorbed + tetanus toxoid adsorbed in Tetanus, diphtheria and pertussis (2 arms), sponsored by Sanofi. Primary endpoints: Diphtheria booster response rate, Tetanus booster response rate and 2 more.
02
Drugs
acellular pertussis vaccinediphtheria toxoid adsorbed + tetanus toxoid adsorbed
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on 2015-003950-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003950-41.